Avalyn Pharmaceuticals Inc.
Filed as AVALYN PHARMACEUTICALS INC (COM SHS), Equity As of 2026 Q2 among managers we track
- 3 Owners
- Max 0.3%
- $3.1M
- 3 new
In 2026 Q2 David Witzke, Davidson Kempner Capital Management, and George Soros opened positions in Avalyn Pharmaceuticals.
Who owns this now
Largest portfolio weights among holders, up to 0.3% (David Witzke, Avidity Partners Management). Not free-float ownership.
Holders
Sorted by value, long equity only, as of 2026 Q2.
| History | |||||
|---|---|---|---|---|---|
| David Witzke, Avidity Partners Management | New 0.32% | 60,000 | $2M | History | |
| Davidson Kempner Capital Management | New 0.01% | 23,000 | $757K | History | |
| George Soros, Soros Fund Management | New <0.01% | 10,000 | $329K | History |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.